Public Reporting


ACO Name and Location

MD Valuecare, LLC
8001 Franklin Farms Drive, Suite 130
Richmond, VA 23229

ACO Primary Contact

Shannon Lodge, ACO Administrator
8001 Franklin Farms Drive, Suite 130
Richmond VA 23229
[email protected]

Organizational Information

ACO Participants

“(ACO participants are not in a joint venture)”
Chickahominy Family Practice

Commonwealth Primary Care

Dominion Medical Associates

Virginia Diabetes and Endocrinology

ACO Participants in Joint Ventures Between ACO Professionals and Hospitals


ACO Governing Body

Voting Member and Vice Chair (11.11%)
Other Representative

Dr. John Kowalski

Dr. Damian Covington

Greg Spruill

Voting Member (11.11%)
Medicare Beneficiary Representative

Dr. Dave Taminger

Dr. Steve Young

Dr. Ken Zelenak

Dr. Shea Puttkammer

Voting Member (11.11%)
ACO Participant Representative, Virginia Diabetes and Endocrinology

Key Clinical and Administrative Leadership

Dr. Ken Zelenak, MD

Medical Director
Quality Assurance/Improvement Officer

Shannon Lodge

ACO Executive/Compliance Official

ACO Committees and Committee Leadership

Quality Committee: Dr. Ken Zelenak, Chair

Managing Committee: Rachel Downey, Chair

Specialist Mobilization Committee: Dr. Mark Monahan, Co-Chair and Dr. Johnny Wong, Co-Chair

Types of ACO Participants, or Combinations of Participants, that Formed the ACO

Network of individual practices of ACO professionals.

Shared Savings and Losses

Amount of Shared Savings and Losses

Third Agreement Period

  • Performance Year 2021, $4,619,483
  • Performance Year 2020, $1,894,328

Second Agreement Period

  • Performance Year 2019, $0
  • Performance Year 2018, $0
  • Performance Year 2017, $3,701,488

First Agreement Period

  • Performance Year 2016, $1,809,663
  • Performance Year 2015, $0
  • Performance Year 2014, $0

How Shared Savings Are Distributed

Third Agreement Period

Performance Year 2021

  • Proportion invested in infrastructure: 11%
  • Proportion invested in redesigned care processes/resources: 15%
  • Proportion of distribution to ACO participants: 74%

Performance Year 2020

  • Proportion invested in infrastructure: 25%
  • Proportion invested in redesigned care processes/resources: 10%
  • Proportion of distribution to ACO participants: 65%

Second Agreement Period

Performance Year 2019 – N/A
Performance Year 2018 – N/A
Performance Year 2017

  • Proportion invested in infrastructure: 41%
  • Proportion invested in redesigned care processes/resources: 10%
  • Proportion of distribution to ACO participants: 49%

First Agreement Period

Performance Year 2016

  • Proportion invested in infrastructure: 100%
  • Invested in redesigned care processes/resources: 0%
  • Proportion of distribution to ACO participants: 0%

Performance Year 2015 – N/A
Performance Year 2014 – N/A

Quality Performance Results

2021 Quality performance results are based on CMS Web Interface

Measure #Measure NameRateACO Mean
ACO-001Diabetes: Hemoglobin A1c (HbA1c) Poor Control7.4112.46
ACO-134Preventative Care and Screening: Screening for Depression and Follow-up Plan91.1874.38
ACO-236Controlling High Blood Pressure82.8974.87
ACO-318Falls: Screening for Future Fall Risk97.7187.03
ACO-110Preventative Care and Screening: Influenza Immunization94.7680.52
ACO-226Preventative Care and Screening: Tobacco Use: Screening and Cessation Intervention100.0080.97
ACO-113Colorectal Cancer Screening84.1573.63
ACO-112Breast Cancer Screening77.7675.11
ACO-438Statin Therapy for the Prevention and Treatment of Cardiovascular Disease88.8084.24
ACO-479Hospital-Wide, 30-Day, All-Cause Unplanned Readmission (HWR) Rate for MIPS Groups0.15660.1540
ACO - MCC1All-Cause Unplanned Admissions for Patients with Multiple Chronic Conditions for ACOs (MCC)34.7933.99
CAHPS-1Getting Timely Care, Appointments, and Information82.3484.67
CAHPS-2How Well Providers Communicate93.8293.56
CAHPS-3Patient’s Rating of Provider91.3092.19
CAHPS-4Access to Specialists73.6878.80
CAHPS-5Health Promotion and Education67.6761.61
CAHPS-6Shared Decision Making61.2260.89
CAHPS-7Health Status and Functional Status70.5871.78
CAHPS-8Care Coordination86.5985.66
CAHPS-9Courteous and Helpful Office Staff91.0191.88
CAHPS-11Stewardship of Patient Resources29.0224.71

For Previous Years’ Financial and Quality Performance Results, please visit

Please note, the Quality ID #: 370 Depression Remission at 12 months quality measure is not included in public reporting due to low sample size.

Fraud and Abuse Waivers

ACO Participation Waiver:

ACO Participation Waiver: The following information describes each arrangement for which our ACO seeks protection under the ACO Participation Waiver, including any material amendment or modification to a disclosed arrangement.

Parties to the arrangement: MD Valuecare, LLC and Laboratory Corporation of America Holdings
Date of arrangement: June 1, 2021
Items, services, goods, or facility provided: Grants to incorporate data analytics platforms to facilitate care coordination and promote outcomes of care. Incorporate Lab Corp’s lab data into clinical data to provide a more robust view of the ACO’s patient population.
Date and nature of any amendments to the arrangement, if applicable: N/A